मूलभूत आँकड़े
LEI | QUIX8Y7A2WP0XRMW7G29 |
CIK | 1090872 |
SEC Filings
SEC Filings (Chronological Order)
August 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended July 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001- |
|
August 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2025 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer |
|
August 27, 2025 |
Exhibit 99.1 Agilent Reports Third-Quarter Fiscal Year 2025 Financial Results Agilent delivers strong revenue growth, raises growth outlook Highlights •Revenue of $1.74 billion for the third quarter ended July 31, 2025, exceeding revenue guidance and representing growth of 10.1% reported and up 6.1% on a core(1) basis compared with the third quarter of 2024. •GAAP net income of $336 million; earni |
|
August 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 11, 2025 AGILENT TECHNOLOGIES, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commiss |
|
July 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 11, 2025 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction of incorporation) (Commissio |
|
July 15, 2025 |
Exhibit 99.1 Agilent Announces CFO Transition SANTA CLARA, California, July 15, 2025 — Agilent Technologies Inc. (NYSE: A) today announced that effective July 31, Senior Vice President and Chief Financial Officer Bob McMahon will step down from his role as he relocates to the East Coast for family reasons and prepares for the next chapter in his career. Following McMahon’s departure, Rodney Gonsal |
|
June 2, 2025 |
Executive Retention Agreement by and between Robert McMahon and the Company Exhibit 10.1 EXECUTIVE RETENTION AGREEMENT This Executive Retention Agreement (“Agreement”) is made by and between Agilent Technologies, Inc., a Delaware Corporation (“Company”) and Robert McMahon (“Executive”) and is entered into as of March 14, 2025 (“Effective Date”). 1.Purpose. The Company recognizes the important goal of retaining Executive as an executive of the Company, and, in furtherance |
|
June 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended April 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001 |
|
May 28, 2025 |
Exhibit 99.1 Agilent Reports Second-Quarter Fiscal Year 2025 Financial Results Agilent delivers strong quarter, enabled by Ignite Transformation Highlights •Revenue of $1.67 billion for the second quarter ended April 30, 2025, representing growth of 6.0% reported and up 5.3% on a core(1) basis compared with the second quarter of 2024. •GAAP net income of $215 million; earnings per share (EPS) of $ |
|
May 28, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 28, 2025 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer of |
|
May 27, 2025 |
AGILENT TECHNOLOGIES, INC. Conflict Minerals Report For the Year Ended December 31, 2024 Exhibit 1.01 AGILENT TECHNOLOGIES, INC. Conflict Minerals Report For the Year Ended December 31, 2024 This Conflict Minerals Report (the “Report”) of Agilent Technologies, Inc. (“Agilent,” the “Company,” “we,” “us,” or “our”) is provided in accordance with Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”) for the reporting period from January 1, 2024, to December 31, 2024 (“Reporti |
|
May 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT AGILENT TECHNOLOGIES, INC. (Exact name of the registrant as specified in its charter) DELAWARE 001-15405 77-0518772 (State of incorporation) (Commission File Number) (IRS Employer Identification No.) 5301 Stevens Creek Blvd., Santa Clara, California 95051 (Address of principal executive of |
|
May 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2025 AGILENT TECHNOLOGIES, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commission |
|
May 21, 2025 |
Exhibit 99.1 Pascal Soriot and Judy Gawlik Brown Named to Agilent Board of Directors Global life-sciences and financial leaders bring decades of health-care, biopharma, and strategic expertise to support Agilent’s next phase of growth SANTA CLARA, California, May 21, 2025— Agilent Technologies Inc. (NYSE: A) today announced that Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder and |
|
May 21, 2025 |
Exhibit 3.1 THIRDSECOND AMENDED AND RESTATED BYLAWS OF AGILENT TECHNOLOGIES, INC. ARticle i CORPORATE OFFICES 1.1 Registered Office. The registered office of the corporation shall be fixed in the Certificate of Incorporation of the corporation. 1.2 Other Offices. The board of directors may at any time establish branch or subordinate offices at any place or places where the corporation is qualified |
|
May 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2025 AGILENT TECHNOLOGIES, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commissi |
|
April 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2025 AGILENT TECHNOLOGIES, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commissi |
|
March 17, 2025 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2025 AGILENT TECHNOLOGIES, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commissi |
|
March 17, 2025 |
Exhibit 3.1 THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF AGILENT TECHNOLOGIES, INC. Agilent Technologies, Inc., a corporation organized and existing under the laws of the State of Delaware, does hereby certify: 1. The name of the corporation is Agilent Technologies, Inc. Agilent Technologies, Inc. was originally incorporated under the name HP Measurement, Inc., and the original Certi |
|
March 3, 2025 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2025 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer of |
|
March 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended January 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 0 |
|
March 3, 2025 |
Exhibit 99.1 TABLE OF CONTENTS Page Forward-Looking Statements 3 PART I Item 1 Business 3 Item 2 Properties 18 PART II Item 7 Management's Discussion and Analysis of Financial Condition and Results of Operations 20 Item 8 Financial Statements and Supplementary Data 45 2 Table of Contents Forward-Looking Statements This report contains forward-looking statements including, without limitation, state |
|
February 26, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2025 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employe |
|
February 26, 2025 |
Exhibit 99.1 Agilent Reports First-Quarter Fiscal Year 2025 Financial Results Delivers solid Q1 results, confirms core growth and EPS for 2025 fiscal year First-quarter fiscal year 2025 •Revenue of $1.68 billion for the first quarter ended Jan. 31, 2025, representing growth of 1.4% reported and up 1.2% on a core(1) basis compared with the first quarter of 2024. •GAAP net income of $318 million; ea |
|
February 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☒ Definitive Additional Materials ☐ Soliciting Material Pursuant to Section 240. |
|
January 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) SCHEDULE 14A Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by |
|
January 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) SCHEDULE 14A Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by |
|
January 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) SCHEDULE 14A Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by |
|
December 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended October 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001-15405 |
|
December 20, 2024 |
Agilent Technologies, Inc. Executive Compensation Clawback Policy Exhibit 97.1 AGILENT TECHNOLOGIES, INC. EXECUTIVE COMPENSATION CLAWBACK POLICY 1.Purpose. The purpose of this Policy is to set forth the circumstances under which Executive Officers of the Company will be required to repay or return certain Excess Awarded Compensation to members of the Company Group. The Compensation Committee of the Board of Directors has adopted this Policy in accordance with th |
|
December 20, 2024 |
Significant subsidiaries of Agilent Technologies, Inc. as of October 31, 202 Exhibit 21.1 SIGNIFICANT SUBSIDIARIES Organized Under the Laws of Agilent Technologies Luxco LLC Luxembourg Agilent Technologies Singapore (Global) Pte Ltd. Singapore Agilent Technologies Singapore (International) Pte. Ltd. Singapore Agilent Technologies World Trade, Inc. United States Dako Denmark ApS Denmark |
|
December 20, 2024 |
Exhibit 19.1 Insider Trading Policy General Prohibition on Trading While in Possession of Material Non-Public Information If you possess information about Agilent that is both material and non-public, you are subject to trading restrictions. You and your immediate family1 cannot legally trade in Agilent securities (including options, put or call options, forward contracts, warrants, swaps and othe |
|
December 13, 2024 |
AGILENT TECHNOLOGIES, INC. LIFE SCIENCES AND DIAGNOSTICS MARKETS SEGMENT (Unaudited) (In millions, except margins data) FY24 Q1 Q2 Q3 Q4 Total Revenue $ 620 $ 604 $ 585 $ 657 $ 2,466 Gross margin % 54.9 % 55.1 % 54.4 % 53.8 % 54.5 % Research and development expenses $ 66 $ 64 $ 59 $ 61 $ 250 Selling, general and administrative expenses $ 160 $ 154 $ 145 $ 152 $ 611 Income from operations $ 114 $ 1 |
|
December 13, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 13, 2024 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employe |
|
November 25, 2024 |
Agilent Announces New Organizational Structure to Support its Market-Focused Strategy Agilent Announces New Organizational Structure to Support its Market-Focused Strategy SANTA CLARA, Calif. |
|
November 25, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 25, 2024 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employe |
|
November 25, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 25, 2024 AGILENT TECHNOLOGIES, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commi |
|
November 25, 2024 |
Exhibit 99.1 Agilent Reports Fourth-Quarter Fiscal Year 2024 Financial Results Delivers solid results in Q4; initiates FY25 guidance Fourth-quarter fiscal year 2024 •Revenue of $1.70 billion, up 0.8% reported and down 0.3% core(1) from the fourth quarter of 2023. •GAAP net income of $351 million; earnings per share (EPS) of $1.22, down 25% from the fourth quarter of 2023. •Non-GAAP(2) net income o |
|
November 12, 2024 |
SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* AGILENT TECHNOLOGIES, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 00846U101 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate bo |
|
September 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 9, 2024 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commi |
|
September 9, 2024 |
Third Supplemental Indenture, dated as of September 9, 2024, between the Company and Citibank, N.A. EX-4.4 Exhibit 4.4 AGILENT TECHNOLOGIES, INC. (as Obligor) and CITIBANK, N.A. (as Trustee) Third Supplemental Indenture Dated as of September 9, 2024 4.750% Senior Notes due 2034 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 SECTION 1.01 Definitions 1 ARTICLE II TERMS OF THE NOTES 3 SECTION 2.01 Title 3 SECTION 2.02 Aggregate Principal Amount 4 SECTION 2.03 Maturity 4 SECTION 2.04 Interest 4 SECT |
|
September 9, 2024 |
Second Supplemental Indenture, dated as of September 9, 2024, between the Company and Citibank, N.A. EX-4.2 Exhibit 4.2 AGILENT TECHNOLOGIES, INC. (as Obligor) and CITIBANK, N.A. (as Trustee) Second Supplemental Indenture Dated as of September 9, 2024 4.200% Senior Notes due 2027 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 SECTION 1.01. Definitions 1 ARTICLE II TERMS OF THE NOTES 4 SECTION 2.01. Title 4 SECTION 2.02. Aggregate Principal Amount 4 SECTION 2.03. Maturity 4 SECTION 2.04. Interest |
|
September 6, 2024 |
Exhibit 107 Calculation of Filing Fee Table 424(b)(5) (Form Type) Agilent Technologies, Inc. |
|
September 6, 2024 |
$1,200,000,000 $600,000,000 4.200% Senior Notes due 2027 $600,000,000 4.750% Senior Notes due 2034 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-281896 Prospectus Supplement (To Prospectus Dated September 3, 2024) $1,200,000,000 $600,000,000 4.200% Senior Notes due 2027 $600,000,000 4.750% Senior Notes due 2034 Agilent Technologies, Inc. is offering $600,000,000 aggregate principal amount of its 4.200% Senior Notes due September 9, 2027 and $600,000,000 aggregate princ |
|
September 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 4, 2024 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commi |
|
September 5, 2024 |
Exhibit 1.1 AGILENT TECHNOLOGIES, INC. $600,000,000 4.200% Senior Notes due 2027 $600,000,000 4.750% Senior Notes due 2034 Underwriting Agreement September 4, 2024 BofA Securities, Inc. J.P. Morgan Securities LLC Mizuho Securities USA LLC and Wells Fargo Securities, LLC As Representatives of the several Underwriters listed in Schedule 1 hereto c/o BofA Securities, Inc. One Bryant Park New York, Ne |
|
September 4, 2024 |
Filed Pursuant to Rule 433 Registration No. 333-281896 Issuer Free Writing Prospectus dated September 4, 2024 Relating to Preliminary Prospectus Supplement dated September 4, 2024 Agilent Technologies, Inc. Pricing Term Sheet $600,000,000 4.200% Senior Notes due 2027 (the “2027 Notes”) $600,000,000 4.750% Senior Notes due 2034 (the “2034 Notes”) Issuer: Agilent Technologies, Inc. Principal Amount: |
|
September 4, 2024 |
SUBJECT TO COMPLETION, DATED SEPTEMBER 4, 2024 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-281896 The information in this preliminary prospectus supplement is not complete and may be changed. We are not using this preliminary prospectus supplement and accompanying prospectus to offer to sell these securities or to solicit offers to buy these securities in any jurisdiction where the offer or sale is not permitted. SU |
|
September 3, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S- 3 (Form Type) Agilent Technologies, Inc. |
|
September 3, 2024 |
Table of Contents Exhibit 99.1 TABLE OF CONTENTS Page Forward-Looking Statements 2 PART I Item 1 Business 2 Item 2 Properties 16 PART II Item 7 Management's Discussion and Analysis of Financial Condition and Results of Operations 17 Item 8 Financial Statements and Supplementary Data 40 1 Table of Contents Forward-Looking Statements This report contains forward-looking statements including, without |
|
September 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 3, 2024 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employe |
|
September 3, 2024 |
Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☒ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) Citibank, N.A. A National Banking Association 13-5266470 (I.R.S. employer identification no.) 388 Greenwich Street, N |
|
September 3, 2024 |
As filed with the Securities and Exchange Commission on September 3, 2024 Table of Contents As filed with the Securities and Exchange Commission on September 3, 2024 Registration No. |
|
August 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended July 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001- |
|
August 21, 2024 |
Exhibit 99.1 Agilent Reports Third-Quarter Fiscal Year 2024 Financial Results Delivers better-than-expected performance; raises mid-point of guidance Highlights •Revenue of $1.58 billion, down 5.6% reported and 4.4% core(1) from the third quarter of 2023. •GAAP net income of $282 million; earnings per share (EPS) of $0.97, up 155% from the third quarter of 2023. •Non-GAAP(2) net income of $385 mil |
|
August 21, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 21, 2024 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer |
|
June 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended April 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001 |
|
May 29, 2024 |
Exhibit 99.1 Agilent Reports Second-Quarter Fiscal Year 2024 Financial Results Full-year outlook revised to reflect slower market recovery Announces plan to repurchase $0.75 billion of its common stock by end of fiscal year Board of directors authorizes new $2.0 billion share repurchase program Highlights •Revenue of $1.57 billion, down 8.4% reported and 7.4% core(1) from the second quarter of 202 |
|
May 29, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2024 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer of |
|
May 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT AGILENT TECHNOLOGIES, INC. (Exact name of the registrant as specified in its charter) DELAWARE 001-15405 77-0518772 (State of incorporation) (Commission File Number) (IRS Employer Identification No.) 5301 Stevens Creek Blvd., Santa Clara, California 95051 (Address of principal executive of |
|
May 28, 2024 |
AGILENT TECHNOLOGIES, INC. Conflict Minerals Report For the Year Ended December 31, 2023 Exhibit 1.01 AGILENT TECHNOLOGIES, INC. Conflict Minerals Report For the Year Ended December 31, 2023 This Conflict Minerals Report(the “Report”) of Agilent Technologies, Inc. (“Agilent,” the “Company,” “we,”“us,” or “our”)is provided in accordance with Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”)for the reporting period from January1, 2023, to December 31, 2023 (“Reporting Ye |
|
May 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 01, 2024 AGILENT TECHNOLOGIES, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorp |
|
May 24, 2024 |
Agilent Announces Hans E. Bishop Has Stepped Down from Board of Directors Exhibit 99.1 Agilent Announces Hans E. Bishop Has Stepped Down from Board of Directors SANTA CLARA, Calif. May 23, 2024 – Agilent Technologies Inc. (NYSE: A) today announced that Hans E. Bishop, president and co-founder of Altos Labs, has stepped down from serving on Agilent’s board of directors. Bishop joined Agilent’s board in July 2017, after holding a range of leadership positions in the pharm |
|
May 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2024 AGILENT TECHNOLOGIES, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commission |
|
May 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 01, 2024 AGILENT TECHNOLOGIES, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commission |
|
May 1, 2024 |
Padraig McDonnell Assumes Agilent CEO Role Exhibit 99.1 Padraig McDonnell Assumes Agilent CEO Role SANTA CLARA, Calif. May 1, 2024 - Agilent Technologies Inc. (NYSE:‑A) today announced that Padraig McDonnell has assumed the role of Agilent CEO, effective immediately. His appointment is part of the company’s CEO transition plan announced Feb. 21. McDonnell is the fourth CEO in Agilent’s history and succeeds Mike McMullen, who will serve as |
|
April 10, 2024 |
A / Agilent Technologies, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0020-agilenttechnologiesin.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: Agilent Technologies Inc Title of Class of Securities: Common Stock CUSIP Number: 00846U101 Date of Event Which Requires Filing of this Statement: March 28, 2024 Check the appropriate box to |
|
March 15, 2024 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2024 AGILENT TECHNOLOGIES, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commissi |
|
March 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended January 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 0 |
|
February 27, 2024 |
Exhibit 99.1 Agilent Reports First-Quarter Fiscal Year 2024 Financial Results Revenue and earnings exceed Q1 guidance Full-year outlook maintained Highlights •Revenue of $1.66 billion, down 5.6% reported and 6.4% core(1) from the first quarter of 2023. •GAAP net income of $348 million; earnings per share (EPS) of $1.18, down 1% from the first quarter of 2023. •Non-GAAP(2) net income of $380 millio |
|
February 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2024 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employe |
|
February 21, 2024 |
Agilent CEO Mike McMullen to Retire; CrossLab Group President Padraig McDonnell Named CEO-Elect Exhibit 99.1 Agilent CEO Mike McMullen to Retire; CrossLab Group President Padraig McDonnell Named CEO-Elect SANTA CLARA, Calif., Feb. 21, 2024– Agilent Technologies, Inc. (NYSE: A) today announced that Padraig McDonnell, president of the Agilent CrossLab Group (ACG) has been named CEO-elect and chief operating officer (COO) of the company, succeeding current President and CEO Mike McMullen who wi |
|
February 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2024 AGILENT TECHNOLOGIES, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commi |
|
February 13, 2024 |
A / Agilent Technologies, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0203-agilenttechnologiesin.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Agilent Technologies Inc Title of Class of Securities: Common Stock CUSIP Number: 00846U101 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box t |
|
February 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) SCHEDULE 14A Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by |
|
January 5, 2024 |
AGILENT TECHNOLOGIES, INC. LIFE SCIENCES AND APPLIED MARKETS SEGMENT (Unaudited) All periods below were recast to reflect the movement of the Cell Analysis division to our Diagnostics and Genomics business segment from our Life Sciences and Applied Markets business segment. (In millions, except margins data) FY23 Q1 Q2 Q3 Q4 Total Revenue $ 943 $ 874 $ 854 $ 839 $ 3,510 Gross margin % 61.5 % 59.8 |
|
January 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2024 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer |
|
December 20, 2023 |
Exhibit 10.20 AGILENT TECHNOLOGIES, INC. 2018 STOCK PLAN STOCK OPTION AWARD AGREEMENT THIS STOCK OPTION AWARD AGREEMENT, including any additional terms for your country in the Country Specific Addendum attached hereto (collectively, this “Award Agreement”),dated as of the date of grant (the “Grant Date”) indicated in your account maintained by the company providing administrative services in conne |
|
December 20, 2023 |
Exhibit 10.22 AGILENT TECHNOLOGIES, INC. 2018 Stock Plan Stock Award Agreement Section 1. Grant of Stock Award. This Stock Award Agreement, including any exhibits and additional terms for your country in the Country Specific Addendum attached hereto (collectively, this “Award Agreement”), dated as of the grant date (the “Grant Date”) indicated in your account maintained by the company providing ad |
|
December 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended October 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001-15405 |
|
December 20, 2023 |
Significant subsidiaries of Agilent Technologies, Inc. as of October 31, 202 Exhibit 21.1 SIGNIFICANT SUBSIDIARIES Organized Under the Laws of Agilent Technologies Luxco LLC Luxembourg Agilent Technologies Luxembourg Holding S.à.r.l. Luxembourg Agilent Technologies Singapore (Global) Pte Ltd. Singapore Agilent Technologies Singapore (Holding) Pte. Ltd. Singapore Agilent Technologies Singapore (International) Pte. Ltd. Singapore Agilent Technologies World Trade, Inc. United |
|
December 20, 2023 |
Agilent Makes Strategic Updates to Organizational Structure Exhibit 99.1 Agilent Makes Strategic Updates to Organizational Structure SANTA CLARA, Calif., Dec. 20, 2023 — Agilent Technologies Inc. (NYSE: A) today announced it has moved the company’s Cell Analysis Division into its Diagnostics and Genomics Group (DGG) as part of a strategy to further strengthen growth opportunities for both organizations. “We believe having the cell analysis team as part of |
|
December 20, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2023 AGILENT TECHNOLOGIES, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commi |
|
December 20, 2023 |
Exhibit 10.19 AGILENT TECHNOLOGIES, INC. 2018 Stock Plan Stock Award Agreement Section 1. Grant of Stock Award. This Stock Award Agreement, including any additional terms for your country in the Country Specific Addendum attached hereto (collectively, this “Award Agreement”), dated as of the grant date (the “Grant Date”) indicated in your account maintained by the company providing administrative |
|
December 20, 2023 |
Exhibit 10.21 AGILENT TECHNOLOGIES, INC. 2018 Stock Plan Officer and Executive Stock Award Agreement Under the Long-Term Performance Program Section 1. Grant of Stock Award. This Stock Award Agreement, including any additional terms for your country in the Country-Specific Addendum attached hereto (collectively, this “Award Agreement”), dated as of the grant date (the “Grant Date”) indicated in yo |
|
November 20, 2023 |
Exhibit 99.1 Agilent Reports Fourth-Quarter Fiscal Year 2023 Financial Results Revenue at the high end of guidance and EPS exceeds guidance Fourth-quarter fiscal year 2023 •Revenue of $1.69 billion, down 8.7% reported and 9.7% core(1) from the fourth quarter of 2022. •GAAP net income of $475 million; earnings per share (EPS) of $1.62, up 32% from the fourth quarter of 2022. •Non-GAAP(2) net income |
|
November 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2023 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employe |
|
November 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2023 AGILENT TECHNOLOGIES, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commis |
|
September 5, 2023 |
Agilent Names Philip Binns to Lead Life Sciences and Applied Markets Group EXHIBIT 99.1 Agilent Names Philip Binns to Lead Life Sciences and Applied Markets Group SANTA CLARA, Calif., Sept. 5, 2023– Agilent Technologies, Inc. (NYSE: A) today announced Philip Binns has been named president of the company’s Life Sciences and Applied Markets Group (LSAG). Binns previously served as vice president and general manager of the Spectroscopy and Vacuum Solutions division for LSAG |
|
September 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 01, 2023 AGILENT TECHNOLOGIES, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Comm |
|
August 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended July 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001- |
|
August 15, 2023 |
Exhibit 99.1 Agilent Reports Third-Quarter Fiscal Year 2023 Financial Results Delivers on Q3; adjusts full-year outlook to reflect softer market conditions Highlights: •Reported revenue of $1.67 billion declined 2.7% year-over-year, and decreased 2.3% on a core(1) basis. •GAAP net income of $111 million with earnings per share (EPS) of $0.38, down 65% from the third quarter of 2022. •Non-GAAP(2) n |
|
August 15, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 15, 2023 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer |
|
June 13, 2023 |
, by and among the Company, the Lenders party thereto and BNP Paribas, as Administrative Agent. EX-10.1 Exhibit 10.1 EXECUTION COPY CREDIT AGREEMENT dated as of June 7, 2023 among AGILENT TECHNOLOGIES, INC., The LENDERS Party Hereto, BNP PARIBAS, as Administrative Agent, CITIBANK, N.A., BANK OF AMERICA, N.A. JPMORGAN CHASE BANK, N.A. and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Syndication Agents and BNP PARIBAS SECURITIES CORP., CITIBANK, N.A. BOFA SECURITIES, INC., JPMORGAN CHASE BANK, N |
|
June 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2023 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction of incorporation) (Commission |
|
May 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended April 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001 |
|
May 24, 2023 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of Form SD EXHIBIT 1.01 AGILENT TECHNOLOGIES, INC. Conflict Minerals Report For the Year Ended December 31, 2022 This Conflict Minerals Report (the “Report”) of Agilent Technologies, Inc. (“Agilent,” the “Company,” “we,” “us,” or “our”) is provided in accordance with Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”) for the reporting period from January 1, 2022, to December 31, 2022 (“Reporti |
|
May 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT AGILENT TECHNOLOGIES, INC. (Exact name of the registrant as specified in its charter) DELAWARE 001-15405 77-0518772 (State of incorporation) (Commission File Number) (IRS Employer Identification No.) 5301 Stevens Creek Blvd., Santa Clara, California 95051 (Address of principal executive of |
|
May 23, 2023 |
Exhibit 99.1 Agilent Reports Second-Quarter Fiscal Year 2023 Financial Results Delivers solid results; adjusts full-year guidance in an increasingly challenging market Highlights: •Revenue of $1.72 billion represents 6.8% reported growth year-over-year; and up 9.5% on a core(1) basis. •GAAP net income of $302 million with earnings per share (EPS) of $1.02, up 12% from the second quarter of 2022. • |
|
May 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2023 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer of |
|
May 22, 2023 |
EXHIBIT 3.1 SECOND AMENDED AND RESTATED BYLAWS OF AGILENT TECHNOLOGIES, INC. Article I CORPORATE OFFICES 1.1 Registered Office. The registered office of the corporation shall be fixed in the Certificate of Incorporation of the corporation. 1.2 Other Offices. The board of directors may at any time establish branch or subordinate offices at any place or places where the corporation is qualified to d |
|
May 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 17, 2023 AGILENT TECHNOLOGIES, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commission |
|
March 17, 2023 |
mended and Restated Certificate of Incorporation. Exhibit 3.1 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF AGILENT TECHNOLOGIES, INC. Agilent Technologies, Inc., a corporation organized and existing under the laws of the State of Delaware, does hereby certify: 1. The name of the corporation is Agilent Technologies, Inc. Agilent Technologies, Inc. was originally incorporated under the name HP Measurement, Inc., and the original Cert |
|
March 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2023 AGILENT TECHNOLOGIES, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commissi |
|
March 3, 2023 |
Exhibit 10.1 13 February 2023 Padraig McDonnell Wilimngton, DE Dear Padraig: Terms & Conditions U.S. Indefinite Relocation I have the pleasure of confirming the terms and conditions which apply to your move from Wilmington, DE to Santa Clara, CA. This letter outlines the terms and conditions of your move for Agilent Technologies, Inc or any affiliated, subsidiary, or successor employer by which yo |
|
March 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended January 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 0 |
|
February 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2023 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employe |
|
February 28, 2023 |
Exhibit 99.1 Agilent Reports First-Quarter Fiscal Year 2023 Financial Results Delivers excellent start to the year; raises full-year guidance Highlights: •Revenue of $1.76 billion represents 5% reported growth year-over-year; and up 10% on a core(1) basis. •GAAP net income of $352 million with earnings per share (EPS) of $1.19, up 28% from the first quarter of 2022. •Non-GAAP(2) net income of $406 |
|
February 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) SCHEDULE 14A Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by |
|
February 9, 2023 |
A / Agilent Technologies Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0182-agilenttechnologiesin.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: Agilent Technologies Inc. Title of Class of Securities: Common Stock CUSIP Number: 00846U101 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box |
|
February 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) SCHEDULE 14A Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by |
|
January 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) SCHEDULE 14A Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by |
|
January 9, 2023 |
Agilent Authorizes $2 Billion Share Repurchase Program EX-99.1 2 a-ex991.htm EX-99.1 Exhibit 99.1 Agilent Authorizes $2 Billion Share Repurchase Program SANTA CLARA, California, January 9, 2023 – Agilent Technologies Inc. (NYSE: A) today announced that its board of directors has approved a new share repurchase program. The 2023 program authorizes the purchase of up to $2 billion of the company’s common stock. “Agilent is committed to balanced capital |
|
January 9, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 09, 2023 AGILENT TECHNOLOGIES, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commis |
|
December 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended October 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001-15405 |
|
December 21, 2022 |
Significant subsidiaries of Agilent Technologies, Inc. as of October 31, 202 Exhibit 21.1 SIGNIFICANT SUBSIDIARIES Organized Under the Laws of Agilent Technologies Luxco S.à.r.l. Luxembourg Agilent Technologies Luxembourg Holding S.à.r.l. Luxembourg Agilent Technologies Singapore (Global) Pte Ltd. Singapore Agilent Technologies Singapore (Holding) Pte. Ltd. Singapore Agilent Technologies Singapore (International) Pte. Ltd. Singapore Agilent Technologies World Trade, Inc. D |
|
November 21, 2022 |
Exhibit 99.1 Agilent Reports Fourth-Quarter and Fiscal Year 2022 Financial Results Outstanding fourth quarter caps off another strong year of performance in 2022 Fourth-quarter fiscal year 2022 ?Revenue of $1.85 billion represents 11% reported growth year-over-year; and up 17% on a core(1) basis. ?GAAP net income of $368 million with earnings per share (EPS) of $1.23, down 15% from the fourth quar |
|
November 21, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2022 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employe |
|
September 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended July 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001- |
|
August 16, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 16, 2022 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer |
|
August 16, 2022 |
Exhibit 99.1 Agilent Reports Third-Quarter Fiscal Year 2022 Financial Results Delivers excellent results; again raises full-year guidance Highlights: ?Revenue of $1.72 billion represents 8% reported growth year-over-year; and up 13% on a core(1) basis. ?GAAP net income of $329 million with earnings per share (EPS) of $1.10, up 28% from the third quarter of 2021. ?Non-GAAP(2) net income of $401 mil |
|
May 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended April 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001 |
|
May 25, 2022 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of Form SD. Exhibit 1.01 AGILENT TECHNOLOGIES, INC. Conflict Minerals Report For the Year Ended December 31, 2021 This Conflict Minerals Report (the ?Report?) of Agilent Technologies, Inc. (?Agilent,? the ?Company,? ?we,? ?us,? or ?our?) is provided in accordance with Rule 13p-1 under the Securities Exchange Act of 1934 (the ?Rule?) for the reporting period from January 1, 2021 to December 31, 2021 (?Reportin |
|
May 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT AGILENT TECHNOLOGIES, INC. (Exact name of the registrant as specified in its charter) DELAWARE 001-15405 77-0518772 (State of incorporation) (Commission File Number) (IRS Employer Identification No.) 5301 Stevens Creek Blvd., Santa Clara, California 95051 (Address of principal executive of |
|
May 24, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2022 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer of |
|
May 24, 2022 |
Exhibit 99.1 Agilent Reports Second-Quarter Fiscal Year 2022 Financial Results Delivers solid results; increases full-year core growth and EPS forecast Highlights: ?Revenue of $1.61 billion represents 5% reported growth; and up 7% on a core(1) basis. ?GAAP net income of $274 million with earnings per share (EPS) of 91 cents, up 30% from the second quarter of 2021. ?Non-GAAP(2) net income of $340 m |
|
April 19, 2022 |
Exhibit 10.1 EXECUTION COPY TERM LOAN AGREEMENT Dated as of April 15, 2022 among AGILENT TECHNOLOGIES, INC., The LENDERS Party Hereto, WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent, BANK OF AMERICA, N.A. and MIZUHO BANK, LTD., as Syndication Agents and WELLS FARGO SECURITIES, LLC BOFA SECURITIES, INC., and MIZUHO BANK, LTD., as Joint Lead Arrangers and Joint Bookrunners TABLE OF |
|
April 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 15, 2022 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction of incorporation) (Commissi |
|
March 17, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 16, 2022 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer o |
|
March 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended January 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 0 |
|
February 22, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 22, 2022 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employe |
|
February 22, 2022 |
Exhibit 99.1 Agilent Reports First-Quarter Fiscal Year 2022 Financial Results Strong Start to 2022; Raising Full-Year Guidance Highlights: ?Revenue of $1.67 billion represents 8% reported growth; and up 9% on a core(1) basis. ?GAAP net income of $283 million with earnings per share (EPS) of $0.93, flat from the first quarter of 2021. ?Non-GAAP(2) net income of $368 million with EPS of $1.21, up 14 |
|
February 9, 2022 |
A / Agilent Technologies Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: Agilent Technologies Inc. Title of Class of Securities: Common Stock CUSIP Number: 00846U101 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is fi |
|
February 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
January 5, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2022 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer |
|
January 5, 2022 |
AGILENT TECHNOLOGIES, INC. LIFE SCIENCES AND APPLIED MARKETS SEGMENT (Unaudited) All periods below were revised to reflect the movement of the chemistries and supplies business and remarketed instruments business from our Agilent CrossLab business segment to our Life Sciences and Applied Markets business segment and the movement of service revenue and cost of sales related to the acquisition of Bi |
|
December 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 21, 2021 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employe |
|
December 17, 2021 |
Significant subsidiaries of Agilent Technologies, Inc. as of October 31, 202 Exhibit 21.1 SIGNIFICANT SUBSIDIARIES Organized Under the Laws of Agilent Technologies Luxco S.?.r.l. Luxembourg Agilent Technologies Luxembourg Holding S.?.r.l. Luxembourg Agilent Technologies Singapore (Global) Pte Ltd. Singapore Agilent Technologies Singapore (Holding) Pte. Ltd. Singapore Agilent Technologies Singapore (International) Pte. Ltd. Singapore Agilent Technologies World Trade, Inc. D |
|
December 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (MARK ONE) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended October 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001-15405 |
|
December 10, 2021 |
Exhibit 10.1 EXECUTION COPY AMENDMENT NO. 4 TO THE CREDIT AGREEMENT Dated as of December 8, 2021 AMENDMENT NO. 4 TO THE CREDIT AGREEMENT (this ?Amendment?) among AGILENT TECHNOLOGIES, INC., a Delaware corporation (the ?Company?), the banks, financial institutions and other institutional lenders parties to the Credit Agreement referred to below (collectively, the ?Lenders?) and BNP PARIBAS, as admi |
|
December 10, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 8, 2021 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer |
|
November 22, 2021 |
Exhibit 99.1 Agilent Reports Fourth-Quarter and Fiscal Year 2021 Financial Results Fourth Quarter Caps Off Record-Setting Performance in 2021 Highlights: Fourth-quarter fiscal year 2021 ?Revenue of $1.66 billion represents 12% reported growth; and up 11% on a core(1) basis. ?GAAP net income of $442 million with earnings per share (EPS) of $1.45, up 104% from the fourth quarter of 2020. ?Non-GAAP(2 |
|
November 22, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 22, 2021 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employe |
|
November 19, 2021 |
Exhibit 99.1 Dr. Otis Brawley Named to Agilent Board of Directors Leading authority on cancer research joins Agilent board SANTA CLARA, Calif., Nov. 18, 2021 ? Agilent Technologies, Inc. (NYSE: A) today announced that Dr. Otis W. Brawley, a Bloomberg Distinguished Professor with the Department of Oncology and Epidemiology at the Johns Hopkins University School of Medicine, has been elected to Agil |
|
November 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2021 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employe |
|
September 23, 2021 |
Exhibit 99.1 Dr. Mikael Dolsten Named to Agilent Board of Directors Pfizer executive brings strong scientific and medical expertise to Agilent board SANTA CLARA, Calif., Sept. 23, 2021 ? Agilent Technologies, Inc. (NYSE: A) today announced that Dr. Mikael Dolsten, chief scientific officer and president, Worldwide Research, Development and Medical, Pfizer Inc. has been elected to Agilent?s board of |
|
September 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 21, 2021 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employ |
|
September 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended July 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001- |
|
August 17, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 17, 2021 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer |
|
August 17, 2021 |
EX-99.1 2 exhibit991-q321pressrelease.htm EX-99.1 Exhibit 99.1 Agilent Reports Third-Quarter Fiscal Year 2021 Financial Results Delivers Very Strong Results, Raising Full-Year Guidance Highlights: •Revenue of $1.59 billion represents an increase of 26% reported growth year-over-year, up 21% on a core(1) basis. •GAAP diluted earnings per share (EPS) of 86 cents, up 34%. •Non-GAAP(2) diluted EPS of |
|
June 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended April 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001 |
|
May 27, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT AGILENT TECHNOLOGIES, INC. (Exact name of the registrant as specified in its charter) DELAWARE 001-15405 77-0518772 (State of incorporation) (Commission File Number) (IRS Employer Identification No.) 5301 Stevens Creek Blvd., Santa Clara, California 95051 (Address of principal executive of |
|
May 27, 2021 |
Exhibit 1.01 – Conflict Minerals Report as required by Items 1.01 and 1.02 of Form SD. Exhibit 1.01 AGILENT TECHNOLOGIES, INC. Conflict Minerals Report For the Year Ended December 31, 2020 This Conflict Minerals Report (the ?Report?) of Agilent Technologies, Inc. (?Agilent,? the ?Company,? ?we,? ?us,? or ?our?) is provided in accordance with Rule 13p-1 under the Securities Exchange Act of 1934 (the ?Rule?) for the reporting period from January 1, 2020 to December 31, 2020 (?Reportin |
|
May 25, 2021 |
Exhibit 99.1 Agilent Reports Second-Quarter Fiscal Year 2021 Financial Results Delivers Strong, Broad-Based Growth Raising Full-Year Outlook on Continued Company Momentum Highlights: ?Revenue of $1.525 billion represents an increase of 23% reported growth year-over-year, up 19% on a core(1) basis. ?GAAP net income of $216 million, or 70 cents per share. ?Non-GAAP(2) net income of $299 million, or |
|
May 25, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 25, 2021 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer of |
|
April 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 21, 2021 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer o |
|
April 22, 2021 |
EXECUTION COPY Exhibit 10.1 INCREMENTAL ASSUMPTION AGREEMENT This INCREMENTAL ASSUMPTION AGREEMENT dated as of April 21, 2021 (this ?Agreement?) is among AGILENT TECHNOLOGIES, INC., a Delaware corporation (the ?Company?), the Lenders parties hereto (which constitute Required Lenders), and BNP PARIBAS, as Administrative Agent. Capitalized terms used but not otherwise defined herein shall have the m |
|
March 18, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2021 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer o |
|
March 12, 2021 |
Exhibit 4.2 AGILENT TECHNOLOGIES, INC. (as Obligor) and CITIBANK, N.A. (as Trustee) First Supplemental Indenture Dated as of March 12, 2021 2.300% Senior Notes due 2031 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS Section 1.01. Definitions 1 ARTICLE II TERMS OF THE NOTES Section 2.01. Title 4 Section 2.02. Aggregate Principal Amount 4 Section 2.03. Maturity 4 Section 2.04. Interest 4 Section 2.05. |
|
March 12, 2021 |
Indenture dated as of March 12, 2021, between the Company and Citibank, N.A. Exhibit 4.1 AGILENT TECHNOLOGIES, INC. (as Obligor) and CITIBANK, N.A. (as Trustee) Indenture Dated as of March 12, 2021 DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.01 Definitions 1 SECTION 1.02 Officer?s Certificates and Opinions 8 SECTION 1.03 Form of Documents Delivered to Trustee 8 SECTION 1.04 Acts of Holders 9 SECTION 1 |
|
March 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2021 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commissi |
|
March 5, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2021 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commissio |
|
March 5, 2021 |
Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-233593 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities To Be Registered Amount to be Registered Maximum Offering Price Per Unit Maximum Aggregate Offering Price Amount of Registration Fee (1) 2.300% Notes due 2031 $850,000,000 99.822% $848,487,000 $92,569.93 TOTAL $850,000,000 ? $848,487,000 $92,569.93 (1) Ca |
|
March 5, 2021 |
Exhibit 1.1 AGILENT TECHNOLOGIES, INC. $850,000,000 2.300% Senior Notes due 2031 Underwriting Agreement March 3, 2021 Barclays Capital Inc. Citigroup Global Markets Inc. and J.P. Morgan Securities LLC As Representatives of the several Underwriters listed in Schedule 1 hereto c/o Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 c/o Citigroup Global Markets Inc. 388 Greenwich Street |
|
March 5, 2021 |
Agilent Technologies Announces Pricing of $850 Million of Senior Notes EX-99.1 Exhibit 99.1 Agilent Technologies Announces Pricing of $850 Million of Senior Notes SANTA CLARA, Calif., March 3, 2021 – Agilent Technologies, Inc. (NYSE: A) today announced the pricing of an underwritten, registered public offering of a series of its senior notes in an aggregate principal amount of $850 million. The offering is being conducted under an automatic shelf registration stateme |
|
March 3, 2021 |
Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-233593 The information in this preliminary prospectus supplement is not complete and may be changed. We are not using this preliminary prospectus supplement and accompanying prospectus to offer to sell these securities or to solicit offers to buy these securities in any jurisdiction where the offer or sale is not permitted. SU |
|
March 3, 2021 |
Filed Pursuant to Rule 433 Registration No. 333-233593 Issuer Free Writing Prospectus dated March 3, 2021 Relating to Preliminary Prospectus Supplement dated March 3, 2021 Agilent Technologies, Inc. Pricing Term Sheet 2.300% Senior Notes due 2031 Issuer: Agilent Technologies, Inc. Principal Amount: $850,000,000 Security Type: Senior Notes Maturity Date: March 12, 2031 Coupon: 2.300% Price to Publi |
|
March 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended January 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 0 |
|
February 25, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
February 16, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 16, 2021 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employe |
|
February 16, 2021 |
Exhibit 99.1 Agilent Reports First-Quarter Fiscal Year 2021 Financial Results Strong start to 2021, raising full-year guidance Highlights: ?Revenue of $1.55 billion represents an increase of 14% reported growth year over year, up 11% on a core(1) basis. ?GAAP net income of $288 million, or 93 cents per share. ?Non-GAAP(2) net income of $328 million, or $1.06 per share. ?Full-year guidance raised w |
|
February 10, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6)* Name of issuer: Agilent Technologies Inc. Title of Class of Securities: Common Stock CUSIP Number: 00846U101 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is fi |
|
February 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
January 11, 2021 |
Regulation FD Disclosure - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 11, 2021 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer |
|
December 18, 2020 |
Significant subsidiaries of Agilent Technologies, Inc. as of October 31, 20 Exhibit 21.1 SIGNIFICANT SUBSIDIARIES Organized Under the Laws of Agilent Technologies World Trade, Inc. Delaware Agilent Technologies Luxembourg Holding S.à.r.l. Luxembourg Agilent Technologies Luxco S.à.r.l. Luxembourg Agilent Technologies Singapore (Holding) Pte. Ltd. Singapore Agilent Technologies Singapore (International) Pte. Ltd. Singapore Agilent Technologies Singapore (Global) Pte Ltd. Si |
|
December 18, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended October 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001-15405 |
|
November 23, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 23, 2020 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employe |
|
November 23, 2020 |
Exhibit 99.1 Agilent Reports Fourth-Quarter and Fiscal Year 2020 Financial Results; Initiates Fiscal 2021 Guidance Highlights: Fourth-quarter fiscal year 2020 •Revenue of $1.48 billion represents 8% reported growth; and up 6% on a core(1) basis with strong growth across all regions and all three businesses. •GAAP net income of $222 million with earnings per share (EPS) of 71 cents, up 15% from the |
|
October 1, 2020 |
As filed with the Securities and Exchange Commission on October 1, 2020 Registration No. |
|
September 1, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended July 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001- |
|
August 18, 2020 |
Exhibit 99.1 Agilent Reports Third-Quarter Fiscal Year 2020 Financial Results Highlights: • Revenue of $1.26 billion represents decline of 1% reported growth year-over-year, down 3.1% on a core(1) basis • GAAP net income of $199 million, or 64 cents per share • Non-GAAP(2) net income of $243 million, or 78 cents per share SANTA CLARA, California, Aug. 18, 2020 - Agilent Technologies Inc. (NYSE: A) |
|
August 18, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 18, 2020 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer |
|
June 4, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2020 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commission |
|
June 4, 2020 |
EX-4.1 Exhibit 4.1 AGILENT TECHNOLOGIES, INC. (as Obligor) and U.S. BANK NATIONAL ASSOCIATION (as Trustee) Second Supplemental Indenture Dated as of June 4, 2020 2.100% Senior Notes due 2030 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS Section 1.01. Definitions 1 ARTICLE II TERMS OF THE NOTES Section 2.01. Title 3 Section 2.02. Aggregate Principal Amount 4 Section 2.03. Maturity 4 Section 2.04. In |
|
June 2, 2020 |
Prospectus Supplement Filed Pursuant to Rule 424(B)(5) Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. |
|
June 2, 2020 |
EX-1.1 Exhibit 1.1 AGILENT TECHNOLOGIES, INC. $500,000,000 2.100% Senior Notes due 2030 Underwriting Agreement June 1, 2020 BofA Securities, Inc. Mizuho Securities USA LLC and Wells Fargo Securities, LLC As Representatives of the several Underwriters listed in Schedule 1 hereto c/o BofA Securities, Inc. One Bryant Park New York, NY 10036 c/o Mizuho Securities USA LLC 1271 Avenue of the Americas Ne |
|
June 2, 2020 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2020 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commission |
|
June 2, 2020 |
Agilent Technologies Announces Pricing of $500 Million of Senior Notes EX-99.1 Exhibit 99.1 Agilent Technologies Announces Pricing of $500 Million of Senior Notes SANTA CLARA, Calif., June 1, 2020 – Agilent Technologies, Inc. (NYSE: A) today announced the pricing of an underwritten, registered public offering of a series of its senior notes in an aggregate principal amount of $500 million. The offering is being conducted under an automatic shelf registration statemen |
|
June 1, 2020 |
Prospectus Supplement Filed Pursuant to Rule 424(B)(5) Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. |
|
June 1, 2020 |
FWP Filed Pursuant to Rule 433 Registration No. 333-233593 Issuer Free Writing Prospectus dated June 1, 2020 Relating to Preliminary Prospectus Supplement dated June 1, 2020 Agilent Technologies, Inc. Pricing Term Sheet 2.100% Senior Notes due 2030 Issuer: Agilent Technologies, Inc. Principal Amount: $500,000,000 Security Type: Senior Notes Maturity Date: June 4, 2030 Coupon: 2.100% Price to Publi |
|
June 1, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended April 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001 |
|
June 1, 2020 |
Agilent Technologies, Inc. 2020 Employee Stock Purchase Plan effective May 1, 2020).* Exhibit 10.1 2020 EMPLOYEE STOCK PURCHASE PLAN (Effective May 1, 2020) 1. PURPOSE. The purpose of this Plan is to provide an opportunity for Employees of Agilent Technologies, Inc. (the “Corporation”) and its Designated Subsidiaries, to purchase Common Stock of the Corporation and thereby to have an additional incentive to contribute to the prosperity of the Corporation. It is the intention of the |
|
June 1, 2020 |
Letter of Terms and Conditions Localization Program by and among Padraig McDonnell and the Company* Exhibit 10.2 Letter of Terms and Conditions LOCALIZATION PROGRAM Padraig McDonnell 26 September 2019 Dear Padraig, This letter outlines the terms and conditions of your localization for Agilent Technologies, Inc or any affiliated, subsidiary, or successor employer by which you are employed (the Company) including compensation, travel, and financial arrangements. You will be localized to the United |
|
May 21, 2020 |
Exhibit 99.1 Agilent Reports Second-Quarter Fiscal Year 2020 Financial Results Highlights: • Revenue of $1.24 billion represents flat reported growth, down 1.7% on a core(1) basis • GAAP net income of $101 million, or 32 cents per share • Non-GAAP(2) net income of $223 million, or 71 cents per share • Strong operating cash flow of $313 million, up 24% versus prior year SANTA CLARA, Calif., May 21, |
|
May 21, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2020 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer of |
|
May 21, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT AGILENT TECHNOLOGIES, INC. (Exact name of the registrant as specified in its charter) DELAWARE 001-15405 77-0518772 (State of incorporation) (Commission File Number) (IRS Employer Identification No.) 5301 Stevens Creek Blvd., Santa Clara, California 95051 (Address of principal executive of |
|
May 21, 2020 |
AGILENT TECHNOLOGIES, INC. Conflict Minerals Report For the Year Ended December 31, 2019 Exhibit 1.01 AGILENT TECHNOLOGIES, INC. Conflict Minerals Report For the Year Ended December 31, 2019 This Conflict Minerals Report (the “Report”) of Agilent Technologies, Inc. (“Agilent,” the “Company,” “we,” “us,” or “our”) is provided in accordance with Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”) for the reporting period from January 1, 2019 to December 31, 2019 (“Reportin |
|
May 8, 2020 |
As filed with the Securities and Exchange Commission on May 8, 2020. Registration No. 333-91121 Registration No. 333-47024 Registration No. 333-150873 Registration No. 333-189051 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-91121 FORM S-8 REGISTRATION STATEMENT NO. 333-47024 FORM S-8 REGISTRATION S |
|
May 8, 2020 |
As filed with the Securities and Exchange Commission on May 8, 2020. Registration No. 333-91121 Registration No. 333-47024 Registration No. 333-150873 Registration No. 333-189051 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-91121 FORM S-8 REGISTRATION STATEMENT NO. 333-47024 FORM S-8 REGISTRATION S |
|
May 8, 2020 |
As filed with the Securities and Exchange Commission on May 8, 2020. Registration No. 333-91121 Registration No. 333-47024 Registration No. 333-150873 Registration No. 333-189051 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-91121 FORM S-8 REGISTRATION STATEMENT NO. 333-47024 FORM S-8 REGISTRATION S |
|
May 8, 2020 |
As filed with the Securities and Exchange Commission on May 8, 2020. Registration No. 333-91121 Registration No. 333-47024 Registration No. 333-150873 Registration No. 333-189051 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-91121 FORM S-8 REGISTRATION STATEMENT NO. 333-47024 FORM S-8 REGISTRATION S |
|
April 20, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2020 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer o |
|
April 20, 2020 |
Exhibit 10.1 AMENDMENT NO. 3 TO CREDIT AGREEMENT This AMENDMENT NO. 3 TO CREDIT AGREEMENT, dated as of April 17, 2020 (this “Amendment”), is made by and among AGILENT TECHNOLOGIES, INC., a Delaware corporation (the “Company”), BNP PARIBAS, as administrative agent for and on behalf of the Lenders (in such capacity, the “Administrative Agent”), and the Lenders listed on the signature pages hereto. C |
|
April 14, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 14, 2020 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer o |
|
April 14, 2020 |
Exhibit 99.1 Agilent Technologies Provides Update on COVID-19 Impact; Sets Second-Quarter Earnings Call for May 21 SANTA CLARA, California, April 14, 2020 - Agilent Technologies, Inc. (NYSE: A) today announced that due to the expanded and evolving nature of the COVID-19 pandemic and resulting effects on customer operations, it is withdrawing its second-quarter and fiscal year 2020 guidance provide |
|
March 30, 2020 |
A / Agilent Technologies, Inc. DEFA14A - - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
March 18, 2020 |
A / Agilent Technologies, Inc. DEFA14A - - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2020 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer o |
|
March 18, 2020 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2020 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer o |
|
March 18, 2020 |
Agilent Technologies to Adjourn Annual Meeting Until April 17, 2020 Agilent Technologies to Adjourn Annual Meeting Until April 17, 2020 SANTA CLARA, California, Mar. |
|
March 4, 2020 |
A / Agilent Technologies, Inc. DEFA14A - - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
March 3, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended January 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 0 |
|
February 18, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 18, 2020 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employe |
|
February 18, 2020 |
Agilent Technologies Reports First Quarter Fiscal Year 2020 Financial Results Exhibit 99.1 Agilent Technologies Reports First Quarter Fiscal Year 2020 Financial Results Highlights: • Revenue of $1.36 billion represents 5.7% reported growth, up 2.4% on a core(1) basis • GAAP net income of $197 million or 63 cents per share • Non-GAAP(2) net income of $252 million, or 81 cents per share • Second-quarter revenue guidance in a range of $1.28 billion to $1.32 billion, with non-G |
|
February 12, 2020 |
A / Agilent Technologies, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* Name of issuer: Agilent Technologies Inc Title of Class of Securities: Common Stock CUSIP Number: 00846U101 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is fil |
|
February 6, 2020 |
Paulp UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
February 6, 2020 |
A / Agilent Technologies, Inc. DEFA14A - - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
January 23, 2020 |
Exhibit 99.1 Agilent Announces CrossLab Group Leadership Transition Mark Doak to Retire May 1, Padraig McDonnell to lead Agilent CrossLab Group SANTA CLARA, California, Jan. 23, 2020 - Agilent Technologies Inc. (NYSE: A) today announced that Mark Doak, Agilent senior vice president and president of the Agilent CrossLab Group, has decided to retire on May 1, 2020. The company has named Padraig McDo |
|
January 23, 2020 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 23, 2020 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer |
|
December 19, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended October 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001-15405 Agilent Technolog |
|
December 19, 2019 |
Exhibit 4.8 Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 As of October 31, 2019, Agilent Technologies, Inc. has Common Stock (as defined below) registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The following description of our Common Stock is a summary and does not purport to b |
|
December 19, 2019 |
Significant subsidiaries of Agilent Technologies, Inc. as of October 31, 2019. EX-21.1 4 a-10312019xexx211.htm EXHIBIT 21.1 Exhibit 21.1 SIGNIFICANT SUBSIDIARIES Organized Under the Laws of Agilent Technologies World Trade, Inc. Delaware Dako ApS Denmark Agilent Technologies Luxembourg Holding S.à.r.l. Luxembourg Agilent Technologies Luxco S.à.r.l. Luxembourg Agilent Technologies Singapore (Holding) Pte. Ltd. Singapore Agilent Technologies Singapore (International) Pte. Ltd. |
|
December 19, 2019 |
EX-3.2 2 a-10312019xexx32.htm EXHIBIT 3.2 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF AGILENT TECHNOLOGIES, INC. Article I CORPORATE OFFICES 1.1 Registered Office. The registered office of the corporation shall be fixed in the Certificate of Incorporation of the corporation. 1.2 Other Offices. The board of directors may at any time establish branch or subordinate offices at any place or places wher |
|
November 25, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 25, 2019 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employe |
|
November 25, 2019 |
Agilent Technologies Reports Fourth-Quarter and Fiscal Year 2019 Financial Results Exhibit 99.1 Agilent Technologies Reports Fourth-Quarter and Fiscal Year 2019 Financial Results Highlights: Fourth-quarter fiscal year 2019 • Revenue of $1.37 billion represents 6% reported growth; and up 4% on a core(1) basis led by strong results from the Agilent CrossLab Group and the Diagnostics and Genomics Group • GAAP net income of $194 million with EPS of 62 cents, up 2% year over year • N |
|
October 22, 2019 |
EX-10.1 2 a-ex1016.htm EX-10.1 EXECUTION COPY AMENDMENT NO. 2 TO CREDIT AGREEMENT This AMENDMENT NO. 2 TO CREDIT AGREEMENT, dated as of October 21, 2019 (this “Amendment”), is made by and among AGILENT TECHNOLOGIES, INC., a Delaware corporation (the “Company”), BNP PARIBAS, as administrative agent for and on behalf of the Lenders (in such capacity, the “Administrative Agent”), and the Lenders list |
|
October 22, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 21, 2019 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commis |
|
September 18, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 18, 2019 AGILENT TECHNOLOGIES, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Comm |
|
September 18, 2019 |
Amended and Restated Bylaws of Agilent Technologies, Inc. Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF AGILENT TECHNOLOGIES, INC. Article I CORPORATE OFFICES Registered Office . The registered office of the corporation shall be fixed in the Certificate of Incorporation of the corporation. Other Offices . The board of directors may at any time establish branch or subordinate offices at any place or places where the corporation is qualified to do business. A |
|
September 16, 2019 |
Indenture, dated as of September 16, 2019, between the Company and U.S. Bank National Association EX-4.1 Exhibit 4.1 AGILENT TECHNOLOGIES, INC. (as Obligor) and U.S. BANK NATIONAL ASSOCIATION (as Trustee) Indenture Dated as of September 16, 2019 DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.01 Definitions 1 SECTION 1.02 Officer’s Certificates and Opinions 8 SECTION 1.03 Form of Documents Delivered to Trustee 8 SECTION 1.04 |
|
September 16, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 16, 2019 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Comm |
|
September 16, 2019 |
EX-4.2 Exhibit 4.2 Execution Version AGILENT TECHNOLOGIES, INC. (as Obligor) and U.S. BANK NATIONAL ASSOCIATION (as Trustee) First Supplemental Indenture Dated as of September 16, 2019 2.750% Senior Notes due 2029 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS Section 1.01. Definitions 1 ARTICLE II TERMS OF THE NOTES Section 2.01. Title 3 Section 2.02. Aggregate Principal Amount 3 Section 2.03. Matu |
|
September 6, 2019 |
Agilent Technologies Announces Pricing of $500 Million of Senior Notes EX-99.1 Exhibit 99.1 Agilent Technologies Announces Pricing of $500 Million of Senior Notes SANTA CLARA, Calif., Sept. 5, 2019 – Agilent Technologies, Inc. (NYSE: A) today announced the pricing of an underwritten, registered public offering of a series of its senior notes in an aggregate principal amount of $500 million. The offering is being conducted under an automatic shelf registration stateme |
|
September 6, 2019 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2019 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commi |
|
September 6, 2019 |
EX-1.1 Exhibit 1.1 AGILENT TECHNOLOGIES, INC. $500,000,000 2.750% Senior Notes due 2029 Underwriting Agreement September 5, 2019 Barclays Capital Inc. J.P. Morgan Securities LLC and MUFG Securities Americas Inc. As Representatives of the several Underwriters listed in Schedule 1 hereto c/o Barclays Capital Inc. 745 Seventh Avenue New York, NY 10019 c/o J.P. Morgan Securities LLC 383 Madison Avenue |
|
September 6, 2019 |
424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-233593 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities To Be Registered Amount to be Registered Maximum Offering Price Per Unit Maximum Aggregate Offering Price Amount of Registration Fee(1) 2.750% Notes due 2029 $500,000,000 99.316% $496,580,000 $60,185.50 TOTAL $500,000,000 $496,580,000 $60,185.50 (1) |
|
September 5, 2019 |
FWP Filed Pursuant to Rule 433 Registration No. 333-233593 Issuer Free Writing Prospectus dated September 5, 2019 Relating to Preliminary Prospectus Supplement dated September 5, 2019 Agilent Technologies, Inc. Pricing Term Sheet 2.750% Senior Notes due 2029 Issuer: Agilent Technologies, Inc. Principal Amount: $500,000,000 Security Type: Senior Notes Maturity Date: September 15, 2029 Coupon: 2.750 |
|
September 5, 2019 |
SUBJECT TO COMPLETION, DATED SEPTEMBER 5, 2019 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-233593 The information in this prospectus supplement is not complete and may be changed. We are not using this preliminary prospectus supplement and accompanying prospectus to offer to sell these securities or to solicit offers to buy these securities in any jurisdiction where the offer or sale is not permitted. SUBJECT |
|
September 3, 2019 |
A / Agilent Technologies, Inc. S-3ASR - - S-3ASR S-3ASR Table of Contents As filed with the Securities and Exchange Commission on September 3, 2019 Registration No. |
|
September 3, 2019 |
EX-4.3 Exhibit 4.3 AGILENT TECHNOLOGIES, INC. (as Obligor) and U.S. BANK NATIONAL ASSOCIATION (as Trustee) Indenture Dated as of [ ], 2019 DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.01 Definitions 1 SECTION 1.02 Officer’s Certificates and Opinions 8 SECTION 1.03 Form of Documents Delivered to Trustee 8 SECTION 1.04 Acts of H |
|
September 3, 2019 |
EX-25.1 Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) U.S. BANK NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 31-0841368 I.R.S. Employer |
|
August 30, 2019 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended July 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For transition period from to Commission File Number: 001- |
|
August 16, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 16, 2019 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commiss |
|
August 14, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2019 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer |
|
August 14, 2019 |
Agilent Technologies Reports Third Quarter Fiscal Year 2019 Financial Results Exhibit 99.1 Agilent Technologies Reports Third Quarter Fiscal Year 2019 Financial Results Highlights: • Revenue of $1.27 billion represents 6 percent reported growth; and up 6 percent(1) on a core basis driven by strength in the pharma, diagnostics, environmental and forensics markets • GAAP net income of $191 million or EPS of $0.60 • Non-GAAP net income of $240 million or EPS of $0.76 (2), up 1 |
|
August 8, 2019 |
Exhibit 10.1 EXECUTION COPY AMENDMENT NO. 1 TO CREDIT AGREEMENT AND INCREMENTAL ASSUMPTION AGREEMENT This AMENDMENT NO. 1 TO CREDIT AGREEMENT AND INCREMENTAL ASSUMPTION AGREEMENT, dated as of August 7, 2019 (this “Agreement”), is made by and among AGILENT TECHNOLOGIES, INC., a Delaware corporation (the “Company”), BNP PARIBAS, as administrative agent for and on behalf of the Lenders (in such capac |
|
August 8, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2019 AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-15405 77-0518772 (State or Other Jurisdiction of Incorporation) (Commissi |
|
May 30, 2019 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE QUARTERLY PERIOD ENDED APRIL 30, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: |
|
May 23, 2019 |
A / Agilent Technologies, Inc. SD - - SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT AGILENT TECHNOLOGIES, INC. (Exact name of the registrant as specified in its charter) DELAWARE 001-15405 77-0518772 (State of incorporation) (Commission File Number) (IRS Employer Identification No.) 5301 Stevens Creek Blvd., Santa Clara, California 95051 (Address of principal executive of |
|
May 23, 2019 |
AGILENT TECHNOLOGIES, INC. Conflict Minerals Report For the Year Ended December 31, 2018 Exhibit 1.01 AGILENT TECHNOLOGIES, INC. Conflict Minerals Report For the Year Ended December 31, 2018 This Conflict Minerals Report (the “Report”) of Agilent Technologies, Inc. (“Agilent,” the “Company,” “we,” “us,” or “our”) is provided in accordance with Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”) for the reporting period from January 1, 2018 to December 31, 2018 (“Reportin |
|
May 14, 2019 |
Exhibit 99.1 Agilent Technologies Reports Second Quarter Fiscal Year 2019 Financial Results Highlights: • Revenue of $1.24 billion represents 3 percent reported growth and 4 percent core revenue(1) growth • GAAP net income of $182 million and EPS of $0.57 • Non-GAAP net income of $228 million or $0.71 per share(2), up 9 percent year-over-year • Full-year revenue outlook revised to $5.085 billion t |